{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:22:14Z","timestamp":1790140934188,"version":"4.0.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Identifying predictors of postsurgical recurrence in patients with rectal cancer is critical for optimizing postoperative management and improving patient outcomes. We aimed to assess the effects of demographic, clinical, and pathological factors on recurrence risk after rectal cancer surgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a secondary analysis of data from patients who underwent curative rectal cancer surgery between 2004 and 2018. A Cox proportional hazards regression model was applied to examine the influence of variables on recurrence risk. Kaplan\u2013Meier curves were used to visualize cumulative hazards.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 961 patients (62.7% male, mean age 63.1\u00a0years), 127 (13.2%) experienced recurrence over a median follow-up of 60\u00a0months. Based on the Cox model (C-index\u00a0=\u00a00.770, likelihood ratio test \u03c72(19)\u00a0=\u00a0127.5, P\u00a0&amp;lt;\u00a00.001), significant predictors of increased recurrence risk included pathologic node stage N1 (hazard ratio 2.92, 95% CI: 1.84\u20134.63, P\u00a0&amp;lt;\u00a00.001) and N2 (4.05, 2.36\u20136.94, P\u00a0&amp;lt;\u00a00.001), as well as fewer than 12 harvested lymph nodes (1.95, 1.31\u20132.90, P\u00a0=\u00a00.001). Moderately differentiated histology reduced recurrence risk (0.49, 0.27\u20130.89, P\u00a0=\u00a00.018), and age (0.98, 0.96\u20130.99, P\u00a0=\u00a00.004) was inversely correlated with recurrence risk. Sex, chemotherapy, pathologic tumor stage, and lymphovascular invasion were not significant predictors of recurrence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study identified key factors associated with recurrence risk after rectal cancer surgery, highlighting the importance of pathologic node stage, lymph node metrics, and histological differentiation. These findings provide a foundation for personalized postoperative management strategies and improving long-term outcomes in rectal cancer patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyaf080","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T08:24:10Z","timestamp":1747383850000},"page":"880-888","source":"Crossref","is-referenced-by-count":1,"title":["Recurrence risk following rectal cancer surgery: a survival analysis of key predictors"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8848-5497","authenticated-orcid":false,"given":"Neda","family":"Gorjizadeh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Sina Hospital, Tehran University of Medical Sciences , Hassan-Abad Square, Imam-Khomeini Ave., P.O. Box: 11365-3876, Tehran ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Hajebi","sequence":"additional","affiliation":[{"name":"Department of General Surgery, School of Medicine, Sina Hospital, Tehran University of Medical Sciences , Hassan-Abad Square, Imam-Khomeini Ave., P.O. Box: 11365-3876, Tehran ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matin","family":"Vahedi","sequence":"additional","affiliation":[{"name":"Department of General Surgery, School of Medicine, Sina Hospital, Tehran University of Medical Sciences , Hassan-Abad Square, Imam-Khomeini Ave., P.O. Box: 11365-3876, Tehran ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mottahedi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Sina Hospital, Tehran University of Medical Sciences , Hassan-Abad Square, Imam-Khomeini Ave., P.O. Box: 11365-3876, Tehran ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Nazar","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Sina Hospital, Tehran University of Medical Sciences , Hassan-Abad Square, Imam-Khomeini Ave., P.O. Box: 11365-3876, Tehran ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2025080402265946600_ref1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamaoncol.2023.5098","article-title":"Incidence of recurrence and time to recurrence in stage I to III colorectal cancer: A Nationwide Danish cohort study","volume":"10","author":"Nors","year":"2024","journal-title":"JAMA Oncol"},{"key":"2025080402265946600_ref2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"2025080402265946600_ref3","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.21037\/jgo-22-942","article-title":"Clinical study on risk factors related to postoperative recurrence or metastasis of rectal cancer: A retrospective cohort study","volume":"13","author":"Wang","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"2025080402265946600_ref4","doi-asserted-by":"publisher","first-page":"8586","DOI":"10.1007\/s00330-021-07920-y","article-title":"The development and validation of a predictive model for recurrence in rectal cancer based on radiological and clinicopathological data","volume":"31","author":"Yeo","year":"2021","journal-title":"Eur Radiol"},{"key":"2025080402265946600_ref5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01.coc.0000214930.78200.4a","article-title":"Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer","volume":"29","author":"Das","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"2025080402265946600_ref6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12957-020-01833-8","article-title":"A lower cut-off for lymph node harvest predicts for poorer overall survival after rectal surgery post neoadjuvant chemoradiotherapy","volume":"18","author":"Yeo","year":"2020","journal-title":"World J Surg Oncol"},{"key":"2025080402265946600_ref7","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/jco.2010.33.1595","article-title":"Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials","volume":"29","author":"Valentini","year":"2011","journal-title":"J Clin Oncol"},{"key":"2025080402265946600_ref8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.6004\/jnccn.2023.7081","article-title":"Value of size and malignant features of lateral lymph nodes in risk stratification at lateral local recurrence of rectal cancer: A National Cohort Study","volume":"22","author":"Geffen","year":"2024","journal-title":"J Natl Comprehensive Cancer Network: JNCCN"},{"key":"2025080402265946600_ref9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/ol.2013.1640","article-title":"Prognostic factors associated with locally recurrent rectal cancer following primary surgery (review)","volume":"7","author":"Cai","year":"2014","journal-title":"Oncol Lett"},{"key":"2025080402265946600_ref10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/sla.0000000000001193","article-title":"Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: The MERCURY II study","volume":"263","author":"Battersby","year":"2016","journal-title":"Ann Surg"},{"key":"2025080402265946600_ref11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00384-020-03737-1","article-title":"Proposal for a post-operative surveillance strategy for stage I colorectal cancer patients based on a novel recurrence risk stratification: A multicenter retrospective study","volume":"36","author":"Ozawa","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"2025080402265946600_ref12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s13167-022-00303-3","article-title":"Radiomics based on readout-segmented echo-planar imaging (RS-EPI) diffusion-weighted imaging (DWI) for prognostic risk stratification of patients with rectal cancer: A two-Centre, machine learning study using the framework of predictive, preventive, and personalized medicine","volume":"13","author":"Liu","year":"2022","journal-title":"EPMA J"},{"key":"2025080402265946600_ref13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3393\/ac.2018.10.01","article-title":"Neutrophil to lymphocyte ratio: A predictive marker for treatment outcomes in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by surgery","volume":"35","author":"Jeon","year":"2019","journal-title":"Ann Coloproctol"},{"key":"2025080402265946600_ref14","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00261-022-03746-4","article-title":"Rectal cancer pelvic recurrence: Imaging patterns and key concepts to guide treatment planning","volume":"48","author":"Inoue","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"2025080402265946600_ref15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41416-023-02384-x","article-title":"An MRI-based scoring system for pretreatment risk stratification in locally advanced rectal cancer","volume":"129","author":"Zhao","year":"2023","journal-title":"Br J Cancer"},{"key":"2025080402265946600_ref16","doi-asserted-by":"publisher","first-page":"e15511-e","DOI":"10.1200\/JCO.2022.40.16_suppl.e15511","article-title":"Recurrence risk stratification model for patients with stage I-III colorectal cancer based on clinicopathological and postoperative ctDNA predictors","volume":"40","author":"Gu","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025080402265946600_ref17","doi-asserted-by":"publisher","first-page":"e0290141","DOI":"10.1371\/journal.pone.0290141","article-title":"Machine learning based prediction of recurrence after curative resection for rectal cancer","volume":"18","author":"Jeon","year":"2023","journal-title":"PloS One"},{"key":"2025080402265946600_ref18","doi-asserted-by":"publisher","first-page":"102987","DOI":"10.1016\/j.arcmed.2024.102987","article-title":"Screening the general population for non-alcoholic fatty liver disease: Model development and validation","volume":"55","author":"Mohammadi","year":"2024","journal-title":"Arch Med Res"},{"key":"2025080402265946600_ref19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12957-019-1718-1","article-title":"Factors predicting recurrence after curative resection for rectal cancer: A 16-year study","volume":"17","author":"Farhat","year":"2019","journal-title":"World J Surg Oncol"},{"key":"2025080402265946600_ref20","doi-asserted-by":"publisher","first-page":"e1548","DOI":"10.1002\/onco.13815","article-title":"Recurrence outcomes less Favorable in T1 rectal cancer than in T1 colon cancer","volume":"26","author":"Chang","year":"2021","journal-title":"Oncologist"},{"key":"2025080402265946600_ref21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1200\/JCO.2018.36.4_suppl.637","article-title":"Phenotypic subtypes and risk of local recurrence after radical resection for rectal cancer","volume":"36","author":"Knight","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025080402265946600_ref22","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/sla.0000000000003453","article-title":"Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity\/truncal liposarcoma","volume":"273","author":"Bartlett","year":"2021","journal-title":"Ann Surg"},{"key":"2025080402265946600_ref23","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1093\/annonc\/mdt378","article-title":"Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma","volume":"24","author":"Hugen","year":"2013","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"2025080402265946600_ref24","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1245\/s10434-015-5029-7","article-title":"Prognostic relevance of mucinous subtype in a population-based propensity score analysis of 40,083 rectal cancer patients","volume":"23","author":"Tarantino","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025080402265946600_ref25","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ejso.2019.03.005","article-title":"Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors","volume":"45","author":"Sun","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2025080402265946600_ref26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ejso.2015.03.233","article-title":"Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery \u00b1 a fluoropyrimidine and surgery + a fluoropyrimidine \u00b1 oxaliplatin","volume":"41","author":"Bujko","year":"2015","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"2025080402265946600_ref27","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol: Official journal of the European society for","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Med Oncol"},{"key":"2025080402265946600_ref28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3892\/ol.2020.12105","article-title":"Patterns of recurrence in patients with curative resected rectal cancer according to different chemoradiotherapy strategies: Does preoperative chemoradiotherapy lower the risk of peritoneal recurrence?","volume":"20","author":"Cho","year":"2020","journal-title":"Oncol Lett"},{"key":"2025080402265946600_ref29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: Long-term results of the randomized polish II study","volume":"30","author":"Cise\u0142","year":"2019","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"2025080402265946600_ref30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S1470-2045(14)70377-8","article-title":"Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): An open-label, multicentre, phase 2, randomised controlled trial","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol"},{"key":"2025080402265946600_ref31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000505668","article-title":"Predictors of early distant relapse in rectal cancer patients submitted to preoperative chemoradiotherapy","volume":"43","author":"Restivo","year":"2020","journal-title":"Oncol Res Treat"},{"key":"2025080402265946600_ref32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/wjcs.wjcs_20_22","article-title":"Perineural and Lymphovascular invasion as histologic predictors of a 5-year local recurrence after curative resection of stages II and III rectal cancer","volume":"11","author":"Behboudi","year":"2022","journal-title":"World J Colorectal Surg"},{"key":"2025080402265946600_ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.11.006","article-title":"Are pathological high-risk features in locally advanced rectal cancer a useful selection tool for adjuvant chemotherapy?","volume":"89","author":"Swets","year":"2018","journal-title":"Eur J Cancer"},{"key":"2025080402265946600_ref34","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1200\/jco.19.00016","article-title":"Oxaliplatin-based adjuvant chemotherapy for rectal cancer after preoperative chemoradiotherapy (ADORE): Long-term results of a randomized controlled trial","volume":"37","author":"Hong","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/8\/880\/63207952\/hyaf080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/8\/880\/63207952\/hyaf080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T06:27:02Z","timestamp":1754288822000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/55\/8\/880\/8133652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,16]]},"published-print":{"date-parts":[[2025,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf080","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,16]]}}}